SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (16735)3/22/2004 10:59:04 AM
From: Bluegreen  Read Replies (1) of 17367
 
Bob, which would you rather have a HIGHLY SPECIFIC predictable and safe medication OR do you like the shotgun approach??? Just my opinions but I am AMAZED at how SPECIFIC Raptiva might be. Doesn't mean it doesn't have a possibility of being highly useful in other indications BUT I am once again AMAZED at how SPECIFIC Raptiva might be. Biologics like Raptiva are EXTREMELY RARE and of course VERY VALUABLE!!!!!!!!!!!!! Raptiva is truly a MIRACLE drug. I can't wait to see how all of this unfolds in the next several years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext